ReviewPublic health reviews2026
From Biobank to "Bio-Think-Tank": Functional Evolution of UK Biobank in Public Health Policy Making.
Review in Public health reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aims to explore the evolving role of the UK Biobank in public health policymaking, particularly its shift from a traditional biobank to a proactive "bio-think tank" and highlight the drivers and necessary elements of this evolution, with a focus on improving its functional impact on policymaking. Methods: Searches were performed in PubMed, Scopus and Google Scholar databases (end of search: August 20, 2025). We followed guidelines for the PRISMA. We identified 683 potentially relevant titles in our search and selected 51 studies in our review, reflecting "bio-think-tank" issues between January 2004 and August 2025. Results: Using a functionalist framework, the study identifies key factors driving the UK Biobank's evolution: limited real-time decision support, rising stakeholder expectations, and the UK's desire to lead in biobank science. It defines the "bio-think tank" concept and contrasts it with traditional biobanks. Conclusion: The UK Biobank's evolution should focus on improving data quality, public trust, accessibility for policymakers, and cross-sector collaboration to strengthen its role as a national research hub and global model for integrating biobank resources with health governance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.